Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening

To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening. Seventy-nine consecutive patients at risk for HCC due to cirrhosis and/or CHB were in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical radiology 2018-05, Vol.73 (5), p.485-493
Hauptverfasser: Tillman, B.G., Gorman, J.D., Hru, J.M., Lee, M.H., King, M.C., Sirlin, C.B., Marks, R.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 493
container_issue 5
container_start_page 485
container_title Clinical radiology
container_volume 73
creator Tillman, B.G.
Gorman, J.D.
Hru, J.M.
Lee, M.H.
King, M.C.
Sirlin, C.B.
Marks, R.M.
description To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening. Seventy-nine consecutive patients at risk for HCC due to cirrhosis and/or CHB were included in this retrospective study. For each patient, the first gadoxetate disodium-enhanced MRI between 2008 through 2014 was analysed. Two independent readers read an anonymised abbreviated image set comprising axial T1-weighted (W) images with fat saturation in the hepatobiliary phase, 20 minutes or more after gadoxetate injection, and axial T2W single-shot fast spin echo images. Each observation >10 mm was scored as negative or suspicious for HCC. Inter-reader agreement was assessed. A composite reference standard was used to determine the per-lesion diagnostic performance for each reader. Inter-reader agreement was substantial (κ = 0.75). The final reference standard showed 27 HCCs in 13 patients (median 21 mm, range 11–100 mm). The two readers each correctly scored 23 as suspicious for HCC (sensitivity = 85.2%), scored a total of 27 and 32 observations as suspicious for HCC (positive predictive value [PPV] = 85.2% and 71.9%), and scored 83 and 78 observations or complete examinations as negative for HCC (negative predictive value [NPV] = 95.2% and 94.9%). The AMRI protocol provides higher per-lesion sensitivity and NPV than reported values for ultrasound, the current recommended technique for screening, and similar per-lesion sensitivity and PPV to reported values for complete dynamic contrast-enhanced MRI. •Diagnostic per-lesion performance of a HCC screening abbreviated MRI is proposed.•The methods rely on retrospectively simulated abbreviated MRI on patients at risk.•The protocol provides higher per-lesion sensitivity than reported for ultrasound.•The protocol provides similar per-lesion sensitivity compared to conventional MRI.•Implementation could reduce cost and decrease examination time.
doi_str_mv 10.1016/j.crad.2017.11.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1977780933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926017305329</els_id><sourcerecordid>1977780933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-8fd2b0444390ce3f70e388af743f53ef516f3140ac79698562f23154547c1fd93</originalsourceid><addsrcrecordid>eNp9kc9O3DAQh62qVVmgL9BD5WMvSf0vTixxQUApEggJtRI3y2uPF6-SeLETBA_Rd67ThR578oz0zafx_BD6TElNCZXftrVNxtWM0LamtCaUv0MrymVTMabu36MVIURViklygA5z3i6tYOIjOmCKCdl0coV-nwezGWOegsU7SFUPOcRxKX1Mgxkt4OixwTkMc28mcHhjXHyGqdTYhRxdmIcKxocFddis1wmewl_w5u4K71Kcoo09Ljb8ADtTOuj7okrYmmTDGIcitwlgDOPmGH3wps_w6fU9Qr--X_w8-1Fd315enZ1eV1ZIOVWdd2xNhBBcEQvctwR41xnfCu4bDr6h0nMqiLGtkqprJPOM00Y0orXUO8WP0Ne9t-z3OEOe9BDyspgZIc5ZU9W2bUcU5wVle9SmmHMCr3cpDCa9aEr0EoPe6iUGvcSgKdUlhjL05dU_rwdw_0be7l6Akz0A5ZdPAZLONsBywpDATtrF8D__HzhXm64</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1977780933</pqid></control><display><type>article</type><title>Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Tillman, B.G. ; Gorman, J.D. ; Hru, J.M. ; Lee, M.H. ; King, M.C. ; Sirlin, C.B. ; Marks, R.M.</creator><creatorcontrib>Tillman, B.G. ; Gorman, J.D. ; Hru, J.M. ; Lee, M.H. ; King, M.C. ; Sirlin, C.B. ; Marks, R.M.</creatorcontrib><description>To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening. Seventy-nine consecutive patients at risk for HCC due to cirrhosis and/or CHB were included in this retrospective study. For each patient, the first gadoxetate disodium-enhanced MRI between 2008 through 2014 was analysed. Two independent readers read an anonymised abbreviated image set comprising axial T1-weighted (W) images with fat saturation in the hepatobiliary phase, 20 minutes or more after gadoxetate injection, and axial T2W single-shot fast spin echo images. Each observation &gt;10 mm was scored as negative or suspicious for HCC. Inter-reader agreement was assessed. A composite reference standard was used to determine the per-lesion diagnostic performance for each reader. Inter-reader agreement was substantial (κ = 0.75). The final reference standard showed 27 HCCs in 13 patients (median 21 mm, range 11–100 mm). The two readers each correctly scored 23 as suspicious for HCC (sensitivity = 85.2%), scored a total of 27 and 32 observations as suspicious for HCC (positive predictive value [PPV] = 85.2% and 71.9%), and scored 83 and 78 observations or complete examinations as negative for HCC (negative predictive value [NPV] = 95.2% and 94.9%). The AMRI protocol provides higher per-lesion sensitivity and NPV than reported values for ultrasound, the current recommended technique for screening, and similar per-lesion sensitivity and PPV to reported values for complete dynamic contrast-enhanced MRI. •Diagnostic per-lesion performance of a HCC screening abbreviated MRI is proposed.•The methods rely on retrospectively simulated abbreviated MRI on patients at risk.•The protocol provides higher per-lesion sensitivity than reported for ultrasound.•The protocol provides similar per-lesion sensitivity compared to conventional MRI.•Implementation could reduce cost and decrease examination time.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2017.11.013</identifier><identifier>PMID: 29246586</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - etiology ; Contrast Media ; Cross-Sectional Studies ; Female ; Gadolinium DTPA ; Humans ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - etiology ; Magnetic Resonance Imaging - methods ; Male ; Middle Aged ; Retrospective Studies ; Sensitivity and Specificity</subject><ispartof>Clinical radiology, 2018-05, Vol.73 (5), p.485-493</ispartof><rights>2017</rights><rights>Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-8fd2b0444390ce3f70e388af743f53ef516f3140ac79698562f23154547c1fd93</citedby><cites>FETCH-LOGICAL-c466t-8fd2b0444390ce3f70e388af743f53ef516f3140ac79698562f23154547c1fd93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2017.11.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29246586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tillman, B.G.</creatorcontrib><creatorcontrib>Gorman, J.D.</creatorcontrib><creatorcontrib>Hru, J.M.</creatorcontrib><creatorcontrib>Lee, M.H.</creatorcontrib><creatorcontrib>King, M.C.</creatorcontrib><creatorcontrib>Sirlin, C.B.</creatorcontrib><creatorcontrib>Marks, R.M.</creatorcontrib><title>Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening. Seventy-nine consecutive patients at risk for HCC due to cirrhosis and/or CHB were included in this retrospective study. For each patient, the first gadoxetate disodium-enhanced MRI between 2008 through 2014 was analysed. Two independent readers read an anonymised abbreviated image set comprising axial T1-weighted (W) images with fat saturation in the hepatobiliary phase, 20 minutes or more after gadoxetate injection, and axial T2W single-shot fast spin echo images. Each observation &gt;10 mm was scored as negative or suspicious for HCC. Inter-reader agreement was assessed. A composite reference standard was used to determine the per-lesion diagnostic performance for each reader. Inter-reader agreement was substantial (κ = 0.75). The final reference standard showed 27 HCCs in 13 patients (median 21 mm, range 11–100 mm). The two readers each correctly scored 23 as suspicious for HCC (sensitivity = 85.2%), scored a total of 27 and 32 observations as suspicious for HCC (positive predictive value [PPV] = 85.2% and 71.9%), and scored 83 and 78 observations or complete examinations as negative for HCC (negative predictive value [NPV] = 95.2% and 94.9%). The AMRI protocol provides higher per-lesion sensitivity and NPV than reported values for ultrasound, the current recommended technique for screening, and similar per-lesion sensitivity and PPV to reported values for complete dynamic contrast-enhanced MRI. •Diagnostic per-lesion performance of a HCC screening abbreviated MRI is proposed.•The methods rely on retrospectively simulated abbreviated MRI on patients at risk.•The protocol provides higher per-lesion sensitivity than reported for ultrasound.•The protocol provides similar per-lesion sensitivity compared to conventional MRI.•Implementation could reduce cost and decrease examination time.</description><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - etiology</subject><subject>Contrast Media</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Gadolinium DTPA</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - etiology</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9O3DAQh62qVVmgL9BD5WMvSf0vTixxQUApEggJtRI3y2uPF6-SeLETBA_Rd67ThR578oz0zafx_BD6TElNCZXftrVNxtWM0LamtCaUv0MrymVTMabu36MVIURViklygA5z3i6tYOIjOmCKCdl0coV-nwezGWOegsU7SFUPOcRxKX1Mgxkt4OixwTkMc28mcHhjXHyGqdTYhRxdmIcKxocFddis1wmewl_w5u4K71Kcoo09Ljb8ADtTOuj7okrYmmTDGIcitwlgDOPmGH3wps_w6fU9Qr--X_w8-1Fd315enZ1eV1ZIOVWdd2xNhBBcEQvctwR41xnfCu4bDr6h0nMqiLGtkqprJPOM00Y0orXUO8WP0Ne9t-z3OEOe9BDyspgZIc5ZU9W2bUcU5wVle9SmmHMCr3cpDCa9aEr0EoPe6iUGvcSgKdUlhjL05dU_rwdw_0be7l6Akz0A5ZdPAZLONsBywpDATtrF8D__HzhXm64</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Tillman, B.G.</creator><creator>Gorman, J.D.</creator><creator>Hru, J.M.</creator><creator>Lee, M.H.</creator><creator>King, M.C.</creator><creator>Sirlin, C.B.</creator><creator>Marks, R.M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201805</creationdate><title>Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening</title><author>Tillman, B.G. ; Gorman, J.D. ; Hru, J.M. ; Lee, M.H. ; King, M.C. ; Sirlin, C.B. ; Marks, R.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-8fd2b0444390ce3f70e388af743f53ef516f3140ac79698562f23154547c1fd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - etiology</topic><topic>Contrast Media</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Gadolinium DTPA</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - etiology</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tillman, B.G.</creatorcontrib><creatorcontrib>Gorman, J.D.</creatorcontrib><creatorcontrib>Hru, J.M.</creatorcontrib><creatorcontrib>Lee, M.H.</creatorcontrib><creatorcontrib>King, M.C.</creatorcontrib><creatorcontrib>Sirlin, C.B.</creatorcontrib><creatorcontrib>Marks, R.M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tillman, B.G.</au><au>Gorman, J.D.</au><au>Hru, J.M.</au><au>Lee, M.H.</au><au>King, M.C.</au><au>Sirlin, C.B.</au><au>Marks, R.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>2018-05</date><risdate>2018</risdate><volume>73</volume><issue>5</issue><spage>485</spage><epage>493</epage><pages>485-493</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><abstract>To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening. Seventy-nine consecutive patients at risk for HCC due to cirrhosis and/or CHB were included in this retrospective study. For each patient, the first gadoxetate disodium-enhanced MRI between 2008 through 2014 was analysed. Two independent readers read an anonymised abbreviated image set comprising axial T1-weighted (W) images with fat saturation in the hepatobiliary phase, 20 minutes or more after gadoxetate injection, and axial T2W single-shot fast spin echo images. Each observation &gt;10 mm was scored as negative or suspicious for HCC. Inter-reader agreement was assessed. A composite reference standard was used to determine the per-lesion diagnostic performance for each reader. Inter-reader agreement was substantial (κ = 0.75). The final reference standard showed 27 HCCs in 13 patients (median 21 mm, range 11–100 mm). The two readers each correctly scored 23 as suspicious for HCC (sensitivity = 85.2%), scored a total of 27 and 32 observations as suspicious for HCC (positive predictive value [PPV] = 85.2% and 71.9%), and scored 83 and 78 observations or complete examinations as negative for HCC (negative predictive value [NPV] = 95.2% and 94.9%). The AMRI protocol provides higher per-lesion sensitivity and NPV than reported values for ultrasound, the current recommended technique for screening, and similar per-lesion sensitivity and PPV to reported values for complete dynamic contrast-enhanced MRI. •Diagnostic per-lesion performance of a HCC screening abbreviated MRI is proposed.•The methods rely on retrospectively simulated abbreviated MRI on patients at risk.•The protocol provides higher per-lesion sensitivity than reported for ultrasound.•The protocol provides similar per-lesion sensitivity compared to conventional MRI.•Implementation could reduce cost and decrease examination time.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29246586</pmid><doi>10.1016/j.crad.2017.11.013</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9260
ispartof Clinical radiology, 2018-05, Vol.73 (5), p.485-493
issn 0009-9260
1365-229X
language eng
recordid cdi_proquest_miscellaneous_1977780933
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - etiology
Contrast Media
Cross-Sectional Studies
Female
Gadolinium DTPA
Humans
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - etiology
Magnetic Resonance Imaging - methods
Male
Middle Aged
Retrospective Studies
Sensitivity and Specificity
title Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A23%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20per-lesion%20performance%20of%20a%20simulated%20gadoxetate%20disodium-enhanced%20abbreviated%20MRI%20protocol%20for%20hepatocellular%20carcinoma%20screening&rft.jtitle=Clinical%20radiology&rft.au=Tillman,%20B.G.&rft.date=2018-05&rft.volume=73&rft.issue=5&rft.spage=485&rft.epage=493&rft.pages=485-493&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2017.11.013&rft_dat=%3Cproquest_cross%3E1977780933%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1977780933&rft_id=info:pmid/29246586&rft_els_id=S0009926017305329&rfr_iscdi=true